Charlie's Holdings, Inc.

CHUC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Revenue $2.0M $3.1M $5.5M $2.7M $4.0M $4.0M $4.5M $6.4M
Cost of Revenue — — — — — — — —
Gross Profit — — — — — — — —
Gross Margin — — — — — — — —
Operating Expenses
Research & Development — $6.0K $37.0K $41.0K $39.0K $52.0K $40.0K $9.0K
SG&A Expense $1.4M $1.5M $1.6M $1.6M $1.8M $2.0M $1.9M $2.1M
Operating Income $-736.0K $-941.0K $99.0K $-742.0K $-42.0K $-1.5M $-2.8M $46.0K
Operating Margin -36.0% -30.8% 1.8% -27.4% -1.1% -37.6% -61.4% 0.7%
Interest Expense — $183.0K $114.0K $121.0K $111.0K $131.0K $56.0K $7.0K
Pretax Income $-967.0K — — $-708.0K — — — $286.0K
Income Tax Expense $0 — — $0 — — — $45.0K
Net Income $-967.0K $-1.0M $-27.0K $-708.0K $32.0K $-1.4M $-1.9M $241.0K
Net Margin -47.3% -34.3% -0.5% -26.2% 0.8% -34.5% -42.0% 3.7%
EPS (Basic) $0.00 $0.00 $0.00 $0.00 $0.00 $-0.01 $-0.01 $0.00
EPS (Diluted) $0.00 $0.00 $0.00 $0.00 $0.00 $-0.01 $-0.01 $0.00
Shares Outstanding (Basic) 242.6M 220.6M 216.1M 216.7M 216.4M 211.9M 212.3M 212.8M
Shares Outstanding (Diluted) 242.6M 220.6M 216.1M 216.7M 245.3M 211.9M 212.3M 244.1M
Dividends Per Share — — — — — — — —
← Newer Page 2 of 8 Older →